|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,760.00 KRW | +1.21% |
|
+5.17% | -45.35% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.21% | +5.17% | -30.63% | -48.14% | -45.35% | +23.08% | -55.40% | -81.45% | - | 111M | |
| +1.70% | +7.41% | +18.25% | +12.10% | +6.77% | +2.50% | +8.18% | -12.39% | +256.42% | 49.92B | |
| +0.92% | +3.93% | +26.81% | +90.92% | +137.59% | +399.71% | +604.02% | +478.19% | - | 40.23B | |
| +1.89% | +8.32% | +12.86% | +19.50% | -8.15% | +26.06% | -6.27% | -16.90% | +207.96% | 34.55B | |
| +2.38% | +6.35% | +10.20% | -4.23% | -2.03% | +21.25% | +55.45% | -12.26% | +915.18% | 33.09B | |
| +3.96% | +10.67% | +7.12% | -1.29% | +6.51% | +8.30% | +37.95% | -18.20% | +153.91% | 27.51B | |
| +2.51% | +5.27% | +30.43% | - | - | - | - | - | - | 17.05B | |
| +2.58% | +5.79% | +22.75% | +11.89% | -0.72% | +73.44% | +135.37% | +210.14% | - | 15.92B | |
| +0.32% | +0.58% | +6.84% | +3.68% | +11.15% | +14.00% | +19.09% | -27.42% | +110.34% | 13.86B | |
| +3.30% | +0.76% | +9.83% | +9.37% | +3.40% | +90.23% | +93.88% | +104.91% | +234.15% | 13.52B | |
| +5.63% | +59.76% | +53.67% | +33.14% | +12.13% | +1,820.34% | +773.22% | +356.85% | +3,046.85% | 13.31B | |
| -1.14% | +1.88% | +15.80% | +51.55% | -5.03% | +15.30% | -28.15% | -19.54% | +148.29% | 13.26B | |
| +0.70% | +6.92% | +27.21% | +32.66% | +15.65% | +46.82% | +11.49% | -38.35% | +178.51% | 11.11B | |
| -0.24% | -0.24% | +36.24% | +33.31% | +20.44% | +33.29% | -12.38% | -36.98% | +151.93% | 11.04B | |
| -2.16% | +7.36% | +29.81% | +27.18% | +2.07% | -1.15% | - | - | - | 10.82B | |
| +0.11% | +0.27% | +52.91% | +57.59% | +76.09% | +180.05% | - | - | - | 9.96B | |
| -0.60% | +4.99% | +53.12% | +32.92% | +45.88% | +153.43% | +385.71% | +101.15% | - | 9.34B | |
| +5.53% | -0.91% | +27.52% | +56.66% | +95.07% | +89.19% | +81.39% | +115.73% | +20.99% | 9.1B | |
| -0.34% | -2.83% | +25.40% | +2.62% | +8.07% | +573.97% | +1,626.40% | +13.01% | - | 8.88B | |
| +5.15% | +7.99% | +35.16% | +26.83% | +50.70% | +157.83% | +462.72% | +183.91% | - | 8.46B | |
| Average | +1.67% | +7.08% | +23.57% | +23.59% | +22.64% | +196.19% | +246.63% | +76.49% | +493.14% | 17.55B | |
| Weighted average by Cap. | +1.81% | +7.83% | +22.27% | +26.70% | +26.81% | +168.87% | +203.26% | +92.05% | +458.48% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
